Full Text
Full Text PDF
Abstract
Background/Aims: Although many regimens, including quadruple, sequential, and concomitant treatment, are used and recommended as first-line or rescue therapies for Helicobacter pylori infection, eradication rates are still below 90% in intention-to-treat analyses. Treatment protocols with substantially high eradication rates and low antibiotic resistance are needed. In this study, we investigated the efficacy of high-dose dual therapy as first-line treatment in a Turkish population.
Materials and Methods: All patients underwent upper gastrointestinal endoscopy for the initial H. pylori status because of dyspeptic symptoms. All patients received a 14-day, high-dose dual therapy comprising rabeprazole (20 mg t.i.d.) and amoxicillin (1 g t.i.d.) for H. pylori eradication. H. pylori stool antigen tests of eradication were administered to all participants at least 4 weeks after the completion of the treatment.
Results: The high-dose dual therapy demonstrated a 91.3% rate of successful eradication of H. pylori infection. Per-protocol success was 94.4% among female patients (n=51) and 89.6% among male patients (n=86); in terms of gender, the differences were not significant (p=0.310). No side effects were observed during the study in any patient. Six other patients did not take adequate doses of the treatment protocol.
Conclusion: High-dose dual therapy with rabeprazole and amoxicillin was highly effective and well tolerated as a first-line therapy for H. pylori eradication.
Most read articles by the same author(s)
- Necmettin KARAEREN, Can UYGURER, Ergün SARAÇOĞLU, Celalettin ÇETİN, Sait BAĞCI, Mustafa GÜLŞEN, Ahmet UYGUN, Kemal DAĞALP, Burhan ŞAHİN, Ahmet ALPER, Mucinous biliary obstruction associated with a cholangiocarcinoma , Turkish Journal of Gastroenterology: Vol. 9 No. 4 (1998): Turkish Journal of Gastroenterology
- Muhammed Fatih Karakaya, Erdem Er, Onur Kırımker, Mesut Gümüşsoy, Emin Bodakçi, Mubin Özercan, Beyza Doğanay Erdoğan, Hale Gökcan, Meltem Koloğlu, Kaan Karayalçın, Cihan Yurdaydın, Acar Tüzüner, Selçuk Haznedaroğlu, Kubilay Çınar, Hasan Özkan, Ramazan Idilman, Management of Biliary Complications in Liver Transplant Recipients with Duct-To-Duct Anastomosis: A Single-Center Experience , Turkish Journal of Gastroenterology: Vol. 34 No. 2 (2023): Turkish Journal of Gastroenterology
- Ahmet UYGUN, Abdurrahman KADAYIFÇI, Sait BAĞCI, Ahmet ERDİL, Salih DEVECİ, Mendane SAKA, Ateş YÜKSEL, Fatih BULUCU, Necmettin KARAEREN, Kemal DAĞALP, L-Carnitine therapy in non-alcoholic steatohepatitis , Turkish Journal of Gastroenterology: Vol. 11 No. 3 (2000): Turkish Journal of Gastroenterology
- Murat Kantarcıoğlu, Hakan Demirci, Ferit Avcu, Yıldırım Karslıoğlu, Mustafa Alpaslan Babayiğit, Bülent Karaman, Kadir Öztürk, Hasan Gürel, Meral Akdoğan Kayhan, Sabite Kaçar, Ayhan Kubar, Gürol Öksüzoğlu, Ali Uğur Ural, Sait Bağcı, Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis , Turkish Journal of Gastroenterology: Vol. 26 No. 3 (2015): Turkish Journal of Gastroenterology
- Ahmet ERDİL, Ahmet TÜZÜN, Abdurrahman KADAYIFÇI, Ahmet UYGUN, İsmail YÜKSEKOL, M. Salih DEVECİ, Kemal DAĞALP, The coexistence of sarcoidosis and hepatitis C: A case report , Turkish Journal of Gastroenterology: Vol. 12 No. 4 (2001): Turkish Journal of Gastroenterology
- Celalettin ÇETİN, Sait BAĞCI, Ahmet UYGUN, Mustafa GÜLŞEN, Abdurrahman KADAYIFÇI, Necmettin KARAEREN, Kemal DAĞALP, Needle-knife papillotomy as a second step procedure , Turkish Journal of Gastroenterology: Vol. 11 No. 2 (2000): Turkish Journal of Gastroenterology
- Hakan Demirci, Sevil Uygun İlikhan, Kadir Öztürk, Yücel Üstündağ, Ömer Kurt, Muammer Bilici, Furuzan Köktürk, Ahmet Uygun, Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection , Turkish Journal of Gastroenterology: Vol. 26 No. 6 (2015): Turkish Journal of Gastroenterology
- Ahmet UYGUN, Abdurrahman KADAYIFÇI, Zeki YEŞİLOVA, M. Cemil SAVAŞ, Yüksel ATEŞ, Yıldırım KARSLIOĞLU, Murat CİĞERİM, Sait BAĞCI, Kemal DAĞALP, Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori , Turkish Journal of Gastroenterology: Vol. 15 No. 4 (2004): Turkish Journal of Gastroenterology
- Yusuf Serdar Sakin, Gürkan Çelebi, Murat Kekilli, Ahmet Uygun, Sait Bağcı, EGJ outflow obstruction must be excluded in patients with high IRP and weak peristalsis , Turkish Journal of Gastroenterology: Vol. 26 No. 3 (2015): Turkish Journal of Gastroenterology
- Ahmet UYGUN, N. Kemal NAZAROĞLU, Celalettin ÇETİN, Ahmet ERDİL, Sait BAĞCI, Mustafa GÜLŞEN, Cengiz KAYAHAN, Necmettin KARAEREN, Kemal DAĞALP, Bile and serum carcinoembryonic (CEA) levels in biliary tract diseases , Turkish Journal of Gastroenterology: Vol. 10 No. 3 (1999): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 31 · Issue 3
Pages
234-238
History
Published Online
March 15, 2020
Copyright
Copyright (c) 2020 Kadir Öztürk, Ömer Kurt, Gürkan Çelebi, Hakan Şarlak, Muhammed Fatih Karakaya, Hakan Demirci, Ali Kılınç, Ahmet Uygun
Affiliations
Kadir Öztürk
Department of Gastroenterology, Gülhane Military Medical Academy, Ankara, Turkey
Ömer Kurt
Department of Gastroenterology, Gülhane Military Medical Academy, Ankara, Turke
Gürkan Çelebi
Department of Gastroenterology, Gülhane Military Medical Academy, Ankara, Turkey
Hakan Şarlak
Department of Gastroenterology, Gulhane School of Medicine, Ankara, Turkey
Muhammed Fatih Karakaya
Department of Gastroenterology, Gulhane School of Medicine, Ankara, Turkey
Hakan Demirci
Department of Gastroenterology, Gülhane Military Medical Academy, Ankara, Turkey
Ali Kılınç
Department of Gastroenterology, Gulhane School of Medicine, Ankara, Turkey
Ahmet Uygun
Departments of Gastroenterology, Gülhane Military Medical Academy, Ankara
Cite this Article
Öztürk, K., Kurt, Ömer, Çelebi, G., Şarlak, H., Karakaya, M. F., Demirci, H., … Uygun, A. (2020). High-dose dual therapy is effective as first-line treatment for Helicobacter pylori infection. Turkish Journal of Gastroenterology, 31(3), 234–238. https://doi.org/10.5152/tjg.2020.18974
Outlines